We recently published a list of Smart Money Ratings For 20 Most Undervalued Stocks. In this article, we are going to take a ...

Shares of IQVIA Holdings Inc. slipped 5.88% to $141.82 Wednesday, on what proved to be an all-around mixed trading session ...

IQVIA Holdings reported strong Q1 earnings with $3.83B in revenue, driven by growth in the Technology & Analytics Solutions ...

This year’s report examines how evolving standards of care, new therapies and benefit design are shaping patient access, ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

As sure as the sun rises, prescription medicine use and total drug spending continue to increase in the U.S. | Last year's ...

IQVIA Holdings Analytics Inc. IQV has reported impressive first-quarter 2025 results, wherein earnings and revenues beat the Zacks Consensus Estimate. Adjusted earnings were $2.70 per share ...

IQVIA Holdings (IQV) came out with quarterly earnings of $2.70 per share, beating the Zacks Consensus Estimate of $2.63 per share. This compares to earnings of $2.54 per share a year ago.

Clinical research company IQVIA (NYSE: IQV) will be reporting earnings tomorrow before the bell. Here’s what to expect. IQVIA beat analysts’ revenue expectations by 0.6% last quarter ...

Ireland’s Health and Safety Executive has criticised a new report revealing the country’s shocking last place in Western Europe for new oncology drug access.

Shares of IQVIA Holdings Inc. IQV shed 3.49% to $150.68 Tuesday, on what proved to be an all-around mixed trading session for ...

Shares of IQVIA Holdings Inc. IQV slid 2.81% to $148.99 Friday, on what proved to be an all-around grim trading session for ...